The European Society of Cardiology and the European Association for the Study of Diabetes: guidelines for diabetes and cardiovascular diseases

2020 ◽  
Vol 15 (3) ◽  
pp. 1-4
Author(s):  
Belinda Linden

Belinda Linden presents a quarterly overview of recently published guidance of relevance to cardiovascular nursing. The significant link between diabetes and cardiovascular disease is reviewed in this update

2011 ◽  
pp. 5-12
Author(s):  
Anh Tien Hoang ◽  
Van Minh Huynh ◽  
Khanh Hoang ◽  
Huu Dang Tran ◽  
Viet An Tran

NT-ProBNP is a high value cardiac biomarker and widely applies in many cardiovascular diseases. The evaluation of concentration of NT-ProBNP needs the concern about age, gender, obesity and especially we need each cut-off point for each cause of cardiovascular disease in evaluation and clinical application. Because NT-ProBNP is a new cardiac marker and has been researched in 5 recent years, the cut-off of NT-ProBNP is still being studied for the clinical application in cardiovascular diseases. Only the cut-off of NT-ProBNP in diagnosis heart failure was guided by European Society of Cardiology. The meaning of introduce cut-off value of value plays an role as pilot study for the other relate study and brings the NT-ProBNP closely approach to clinical application.


2020 ◽  
Vol 15 (12) ◽  
pp. 1-6
Author(s):  
Belinda Linden

Belinda Linden presents a quarterly overview of recently published guidance of relevance to cardiovascular nursing. This update reviews the 2020 guidelines from the European Society of Cardiology and the European Association of Cardio-Thoracic Surgery regarding the diagnosis and management of atrial fibrillation.


2018 ◽  
Vol 7 (05) ◽  
pp. 379-383
Author(s):  
Jian Li ◽  
Peter Angerer

ZusammenfassungBisher wurde Stress als Prognosefaktor bei koronarer Herzkrankheit nur wenig beachtet. Wir möchten in diesem Artikel einen aktualisierten und umfassenden Überblick darüber geben, welche Rolle Stress bei der Prognose der koronaren Herzkrankheit spielen könnte. Stress wurde in unterschiedlichen Domänen gemessen. Die Synthese der Forschungsevidenz lässt vermuten, dass Stress das Risiko für wiederholte klinische Ereignisse bei Patienten mit koronarer Herzkrankheit um 55% (95%-Konfidenzintervall 32 – 83%) erhöhen kann. Die „European Guidelines on Cardiovascular Disease Prevention in Clinical Practice“, 2016 von der European Society of Cardiology veröffentlicht, weisen besonders auf die Rolle von Stress und psychosozialen Risikofaktoren hin. Insbesondere die „Cardiac Rehabilitation Section“ der European Association of Cardiovascular Prevention and Rehabilitation schlägt eine 2-stufige Evaluation eines potenziellen Risikos durch Stress für die klinisch-kardiologische Praxis vor.


2020 ◽  
Vol 25 (4) ◽  
pp. 3839
Author(s):  
F. Cosentino ◽  
P. J. Grant ◽  
V. Aboyans ◽  
G. J. Bailey ◽  
А. Ceriello ◽  
...  

The Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD)


Sign in / Sign up

Export Citation Format

Share Document